Jan De Waele (0000-0003-1017-9748)

Personal information

Biography

Jan De Waele is a surgery-trained intensivist and works at the surgical ICU of the Ghent University Hospital in Belgium. Clinical interests include severe infections and abdominal catastrophes such as the abdominal compartment syndrome. He has a specific interest in infections in critically ill patients and his research activities currently focus on optimising antibiotic therapy in severely ill, infected patients to improve outcome and combat resistance development.

Activities

Collapse all

European Society of Intensive Care Medicine: Brussels, Brussels, BE

2022 to present | President Elect

Service

Jan De Waele

https://orcid.org/0000-0003-1017-9748

Personal information

Emails & domains

Verified email domains

Other IDs

Keywords

Biography

Activities

Professional activities (4)

European Society of Intensive Care Medicine: Brussels, Brussels, BE

European Society of Intensive Care Medicine: Brussels, BE

European Society of Intensive Care Medicine: Brussels, BE

European Society of Intensive Care Medicine: Brussels, BE

Funding (3)

Optimaliseren van antibiotica therapie voor ernstige infecties op intensieve zorg

Antibiotica behandeling op maat van de patient voor ernstige infecties op intensieve zorg

Nieuwe strategieën in de behandeling van ernstige acute pancreatitis : een kritische analyse.

Works (50 of 229)

Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU study

Does artificial intelligence close gaps in clinical pharmacology in the ICU?

The impact of Intensive Care Strain on Patients’ Outcomes during COVID-19 - a UNITE COVID study

Environmental sustainability in intensive care: the path forward. An ESICM Green Paper

Selective digestive tract decontamination implementation

A critical role for HNF4α in polymicrobial sepsis-associated metabolic reprogramming and death

Characteristics of co-infection and secondary infection amongst critically ill COVID-19 patients in the first two waves of the pandemic

Designing a Pharmacokinetic Machine Learning Model for Optimizing Beta-Lactam Antimicrobial Dosing in Critically Ill Patients

Environmental sustainability and antimicrobials: an underestimated problem with far-reaching consequences

The environmental impact of laboratory measurements in high-resource ICUs

Optimized Treatment of Nosocomial Peritonitis

Selective digestive decontamination - Pro

Generalizable calibrated machine learning models for real-time atrial fibrillation risk prediction in ICU patients

Potential of Urine Biomarkers CHI3L1, NGAL, TIMP-2, IGFBP7, and Combinations as Complementary Diagnostic Tools for Acute Kidney Injury after Pediatric Cardiac Surgery: A Prospective Cohort Study

Adequate Antimicrobial Dosing in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: Where to Go from Here?

Source control in the management of sepsis and septic shock

Fluid Management, Intra-Abdominal Hypertension and the Abdominal Compartment Syndrome: A Narrative Review

Epidemiology and age-related mortality in critically ill patients with intra-abdominal infection or sepsis: an international cohort study

Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the ‘Maximum Tolerable Dose’

The Role of Abdominal Drain Cultures in Managing Abdominal Infections

Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units

Corrigendum to “Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 Era (PPE-SAFE): An international survey” [Journal of Critical Care, Volume 59, October 2020, Pages 70–75](S088394412030592X)(10.1016/j.jcrc.2020.06.005)

Editorial: The gastrointestinal system in critical care: current insights and perspectives

Empiric cone-beam CT-guided embolization in acute lower gastrointestinal bleeding

Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal Clearance

The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study

The future of antimicrobial dosing in the ICU: an opportunity for data science

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.

Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Pilot study of oral fluid and plasma meropenem and piperacillin concentrations in the intensive care unit.

Augmented renal clearance in critically ill COVID-19 patients: Forewarned is forearmed.

Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey.

Initial antimicrobial management of sepsis.

A three-day antimicrobial course for community-acquired pneumonia? Still no evidence in intensive care unit

Development and validation of a liquid chromatography high-resolution mass spectrometry orbitrap method for the sensitive quantification of amoxicillin, piperacillin, tazobactam and meropenem in human faeces.

Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?

A Clinician's Guide to Management of Intra-Abdominal Hypertension and Abdominal Compartment Syndrome in Critically Ill Patients

Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)

Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study

Antimicrobial De-Escalation in the ICU: From Recommendations to Level of Evidence

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper<inf>#</inf>

Conventional amphotericin B must be avoided in Candida infections

Erratum to ‘When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit’ [Clin Microbiol Infect 26 (1) (January 2020) 35–40] (Clinical Microbiology and Infection (2020) 26(1) (35–40), (S1198743X19303969), (10.1016/j.cmi.2019.07.007))

European intensive care physicians' experience of infections due to antibiotic-resistant bacteria

How to improve research on management of critically ill patients: Lessons learned from negative randomised clinical trials in the intensive care unit

Improving care for the ICU patient with suspected infection: a multidisciplinary perspective

International variation in the management of severe COVID-19 patients

Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia

Multidrug Resistant bacteria in ICU: Fact or myth

Peer review (22 reviews for 2 publications/grants)